The slip
PARKINSON RECEIPTno. 14029
29 Oct 2026, 11:17 UTCmicroglia, braak
predictionPOU2F2 in microglia tracks Braak Lewy-body stage
registeredeb9219b4725f1c59
discovery-0.14 p=0.718 n=9
replication+0.37 p=0.329 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.14, p 0.718)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT7cca7a270b54b8898e2374b5…
follows 9888a581e5f6…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 14029: POU2F2 in microglia, braak
- power
- full sample +0.04 (p 0.881, n 18), 95% CI -0.44 to +0.50. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.05 (p 0.840, n 18). does not hold up.
- composition
- microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: +0.07 (p 0.774, n 18). could be the mix.
- skeptic
- leave-one-out range -0.10 to +0.14, sign flips 4; without severely affected donors +0.04 (p 0.881, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for POU2F2 in microglia.
case closed: nothing better to follow up.